Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL6457535

CC(C)Oc1cc(O)cc2ncnc(Nc3c(Cl)cnc4c3OCO4)c12.O=C(O)C(F)(F)F

nearest known ligand 0.47

Full drug profile on Sugi Atlas →

Predicted protein targets (top 9)

geneUniProtsupporting neighboursconfidence
SRC P12931 16/20 0.47
KDR P35968 10/20 0.47
EGFR P00533 3/20 0.42
BMPR1B O00238 1/20 0.37
BMPR1A P36894 1/20 0.37
ACVR1B P36896 1/20 0.37
TGFBR1 P36897 1/20 0.37
ACVRL1 P37023 1/20 0.37
ACVR1 Q04771 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL3194161 1.00 SRC (0.47) SRCKDREGFRBMPR1BBMPR1A
SCHEMBL3196521 0.93 SRC (0.51) SRCKDREGFR
SCHEMBL3196290 0.81 SRC (0.67) SRCKDREGFRBMPR1BBMPR1A
SCHEMBL4031150 0.81 SRC (0.50) SRCKDREGFR
Trifluoroacetic Acid SCHEMBL6829065 0.80 SRC (0.57) SRCKDREGFR
SCHEMBL3192110 0.79 SRC (0.64) SRCKDREGFR
SCHEMBL3184784 0.79 SRC (0.62) SRCKDREGFRBMPR1BBMPR1A
Trifluoroacetic Acid SCHEMBL6823695 0.78 SRC (0.54) SRCKDREGFR
SCHEMBL3205180 0.76 SRC (0.55) SRCKDREGFR
Azd-0424 SCHEMBL3202072 0.76 SRC (0.73) SRCKDREGFRBMPR1BBMPR1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1562612-A1 COMBINATION PRODUCT OF INHIBITOR OF THE SRC FAMILY OF NON-RECEPTOR TYROSINE KINASES AND GEMCITABINE Astrazeneca AB (SE) 2005-08-17 EP disclosed
WO-2004043472-A1 COMBINATION PRODUCT OF INHIBITOR OF THE SRC FAMILY OF NON-RECEPTOR TYROSINE KINASES AND GEMCITABINE ASTRAZENECA AB (SE) 2004-05-27 WO disclosed